Publications

  • Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication (2023). Goodwin, Guy M., Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stephanie Knatz Peck, Hollie Simmons, Claudia Sisa, Susan C. Stansfield, Joyce Tsai, Sam Williams, and Ekaterina Malievskaia. Neuropsychopharmacology 48 (10):1492-1499.
  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life (2023). Goodwin, G. M., Aaronson, S. T., Alvarez, O., Atli, M., Bennett, J. C., Croal, M., DeBattista, C., Dunlop, B. W., Feifel, D., Hellerstein, D. J., Husain, M. I., Kelly, J. R., Lennard-Jones, M. R., Licht, R. W., Marwood, L., Mistry, S., Páleníček, T., Redjep, O., Repantis, D., Schoevers, R. A., Septimus, B., Simmons, H. J., Soares, J. C., Somers, M., Stansfield, S. C., Stuart, J. R., Tadley, H. H., Thiara, N. K., Tsai, J., Wahba, M., Williams, S., Winzer, R. I., Young, A. H., Young, M. B., Zisook, S. & Malievskaia, E. (2023). J Affect Disord 327, 120-127.
  • Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis (2023). Kelly, J. R., Clarke, G., Harkin, A., Corr, S. C., Galvin, S., Pradeep, V., Cryan, J. F., O'Keane, V. & Dinan, T. G. Int J Clin Health Psychol 23, 100349.
  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022). Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., Burke, L., Campbell-Coker, K., Carhart-Harris, R., Cattell, J., Daniel, A., DeBattista, C., Dunlop, B. W., Eisen, K., Feifel, D., Forbes, M., Haumann, H. M., Hellerstein, D. J., Hoppe, A. I., Husain, M. I., Jelen, L. A., Kamphuis, J., Kawasaki, J., Kelly, J. R., Key, R. E., Kishon, R., Knatz Peck, S., Knight, G., Koolen, M. H. B., Lean, M., Licht, R. W., Maples-Keller, J. L., Mars, J., Marwood, L., McElhiney, M. C., Miller, T. L., Mirow, A., Mistry, S., Mletzko-Crowe, T., Modlin, L. N., Nielsen, R. E., Nielson, E. M., Offerhaus, S. R., O'Keane, V., Páleníček, T., Printz, D., Rademaker, M. C., van Reemst, A., Reinholdt, F., Repantis, D., Rucker, J., Rudow, S., Ruffell, S., Rush, A. J., Schoevers, R. A., Seynaeve, M., Shao, S., Soares, J. C., Somers, M., Stansfield, S. C., Sterling, D., Strockis, A., Tsai, J., Visser, L., Wahba, M., Williams, S., Young, A. H., Ywema, P., Zisook, S. & Malievskaia, E. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med 387, 1637-1648.
  • Psychedelic perceptions: mental health service user attitudes to psilocybin therapy (2022). Corrigan, K., Haran, M., McCandliss, C., McManus, R., Cleary, S., Trant, R., Kelly, Y., Ledden, K., Rush, G., O'Keane, V. & Kelly, J. R. Ir J Med Sci 191, 1385-1397.
  • The psychedelic renaissance: the next trip for psychiatry? (2022). Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C. & O'Keane, V. Ir J Psychol Med 39, 335-339.
  • Psychedelic science in post-COVID-19 psychiatry (2021). Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., Brennan, C. & O'Keane, V. (2020). Ir J Psychol Med 38, 93-98.